Christopher John Harding

Christopher John Harding

Auto-generated profile, based on publicly available information

Christopher John Harding

University of Liverpool

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
GHGareth W. Hughes
Gareth W. Hughes
SHStephen C. L. Hall
Stephen C. L. Hall
CLClaire S. Laxton
Claire S. Laxton
PSPooja Sridhar
Pooja Sridhar
AMAmirul H. Mahadi
Amirul H. Mahadi
TKTimothy J. Knowles
Timothy J. Knowles

23 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CHChristopher J. Harding
Christopher J. Harding
SHSimona G. Huwiler
Simona G. Huwiler
HSHannah Somers
Hannah Somers
CLCarey Lambert
Carey Lambert
LRLuke J. Ray
Luke J. Ray
ALAndrew L. Lovering
Andrew L. Lovering
Lysozymes are among the best-characterized enzymes, acting upon the cell wall substrate peptidoglycan. Here, examining the invasive bacterial periplasmic predator Bdellovibrio bacteriovorus, we report a diversified lysozyme, DslA, which acts, unusually, upon (GlcNAc-) deacetylated peptidoglycan. B. bacteriovorus are known to deacetylate the peptidoglycan of the prey bacterium, generating an important chemical difference between prey and self walls and implying usage of a putative deacetyl-specific “exit enzyme”. DslA performs this role, and ΔDslA strains exhibit a delay in leaving from prey. The structure of DslA reveals a modified lysozyme superfamily fold, with several adaptations. Biochemical assays confirm DslA specificity for deacetylated cell wall, and usage of two glutamate residues for catalysis. Exogenous DslA, added ex vivo, is able to prematurely liberate B. bacteriovorus from prey, part-way through the predatory lifecycle. We define a mechanism for specificity that invokes steric selection, and use the resultant motif to identify wider DslA homologues.

29 June 2023 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
CHChristopher John Harding
Christopher John Harding
MBMarcus Bischoff
Marcus Bischoff
MBMegan Bergkessel
Megan Bergkessel
CCClarissa Melo Czekster
Clarissa Melo Czekster
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious illness, especially in immunocompromised individuals. P. aeruginosa forms biofilms that contribute to growth and persistence in a wide range of environments. Here we investigated the aminopeptidase, P. aeruginosa aminopeptidase (PaAP) from P. aeruginosa, which is highly abundant in the biofilm matrix. PaAP is associated with biofilm development and contributes to nutrient recycling. We confirmed that post-translational processing was required for activation and PaAP is a promiscuous aminopeptidase acting on unstructured regions of peptides and proteins. Crystal structures of wild-type enzymes and variants revealed the mechanism of autoinhibition, whereby the C-terminal propeptide locks the protease-associated domain and the catalytic peptidase domain into a self-inhibited conformation. Inspired by this, we designed a highly potent small cyclic-peptide inhibitor that recapitulates the deleterious phenotype observed with a PaAP deletion variant in biofilm assays and present a path toward targeting secreted proteins in a biofilm context.

25 August 2022 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
ESEmmajay Sutherland
Emmajay Sutherland
CHChristopher John Harding
Christopher John Harding
CCClarissa Melo Czekster
Clarissa Melo Czekster
Cyclodipeptide synthases (CDPSs) generate a wide range of cyclic dipeptides using aminoacylated tRNAs as substrates. Histidine-containing cyclic dipeptides have important biological activities as anticancer and neuroprotective molecules. Out of the 120 experimentally validated CDPS members, only two are known to accept histidine as a substrate yielding cyclo(His-Phe) and cyclo(His-Pro) as products. It is not fully understood how CDPSs select their substrates, and we must rely on bioprospecting to find new enzymes and novel bioactive cyclic dipeptides. Here, we developed an in vitro system to generate an extensive library of molecules using canonical and non-canonical amino acids as substrates, expanding the chemical space of histidine-containing cyclic dipeptide analogues. To investigate substrate selection we determined the structure of a cyclo(His-Pro)-producing CDPS. Three consecutive generations harbouring single, double and triple residue substitutions elucidated the histidine selection mechanism. Moreover, substrate selection was redefined, yielding enzyme variants that became capable of utilising phenylalanine and leucine. Our work successfully engineered a CDPS to yield different products, paving the way to direct the promiscuity of these enzymes to produce molecules of our choosing.

15 January 2021 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
CHChristopher J. Harding
Christopher J. Harding
ESEmmajay Sutherland
Emmajay Sutherland
JHJane G. Hanna
Jane G. Hanna
DHDouglas Houston
Douglas Houston
CCClarissa M. Czekster
Clarissa M. Czekster
Cyclodipeptide synthases (CDPSs) produce a variety of cyclic dipeptide products by utilising two aminoacylated tRNA substrates. We sought to investigate the minimal requirements for substrate usage in this class of enzymes as the relationship between CDPSs and their substrates remains elusive. Here, we investigated the Bacillus thermoamylovorans enzyme, BtCDPS, which synthesises cyclo(L-Leu–L-Leu). We systematically tested where specificity arises and, in the process, uncovered small molecules (activated amino esters) that will suffice as substrates, although catalytically poor. We solved the structure of BtCDPS to 1.7 Å and combining crystallography, enzymatic assays and substrate docking experiments propose a model for how the minimal substrates interact with the enzyme. This work is the first report of a CDPS enzyme utilizing a molecule other than aa-tRNA as a substrate; providing insights into substrate requirements and setting the stage for the design of improved simpler substrates.

23 August 2019 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Open access
PDF file
RLRosalba Lepore
Rosalba Lepore
AKAndriy Kryshtafovych
Andriy Kryshtafovych
MAMarkus Alahuhta
Markus Alahuhta
HVHarshul A. Veraszto
Harshul A. Veraszto
YBYannick J. Bomble
Yannick J. Bomble
TSTorsten Schwede
Torsten Schwede
The functional and biological significance of selected CASP13 targets are described by the authors of the structures. The structural biologists discuss the most interesting structural features of the target proteins and assess whether these features were correctly reproduced in the predictions submitted to the CASP13 experiment.